Trials / Active Not Recruiting
Active Not RecruitingNCT06924684
High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI
Efficacy Of High-Dose Rosuvastatin Preloading Before Primary Percutaneous Coronary Intervention In Patients Suffering From St-Elevation Myocardial Infarction
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- Sponsor
- Sheikh Zayed Federal Postgraduate Medical Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy of high dose rosuvastatin preloading vs placebo before primary PCI in terms of MACE at 30 days
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Statin monotherapy (rosuvastatin or atorvastatin) | Tab Rosuvastatin 40mg (weight) at presentation. Tab Rosuvastatin 20mg at night for 30 days. |
| DRUG | Placebo | Placebo caspule |
Timeline
- Start date
- 2024-12-02
- Primary completion
- 2025-06-23
- Completion
- 2025-07-02
- First posted
- 2025-04-11
- Last updated
- 2025-04-11
Locations
2 sites across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06924684. Inclusion in this directory is not an endorsement.